Marco Zingg
Directeur/Membre du Conseil chez 4D Lifetec AG
Profil
Marco Zingg founded DT Swiss Group AG in 1994.
Mr. Zingg also currently works at 4D Lifetec AG, as Director from 2019.
Postes actifs de Marco Zingg
Sociétés | Poste | Début |
---|---|---|
4D Lifetec AG
4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | Directeur/Membre du Conseil | 01/07/2019 |
Anciens postes connus de Marco Zingg
Sociétés | Poste | Fin |
---|---|---|
DT Swiss Group AG
DT Swiss Group AG Motor VehiclesConsumer Durables DT Swiss Group AG provides components for bicycles. The company offers integrated production planning and control, online reporting in all business segments worldwide, comprehensive intercompany settlement and multi-plant processing services. DT Swiss Group is headquartered in Biel, Switzerland. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
DT Swiss Group AG
DT Swiss Group AG Motor VehiclesConsumer Durables DT Swiss Group AG provides components for bicycles. The company offers integrated production planning and control, online reporting in all business segments worldwide, comprehensive intercompany settlement and multi-plant processing services. DT Swiss Group is headquartered in Biel, Switzerland. | Consumer Durables |
4D Lifetec AG
4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | Health Technology |